Nvidia's plans to dominate biotech AI

Commentary on an Endpoints article

Endpoints published an article on Nvidia NVDA 0.00%↑ and their biotech pitch for mainly AI.

There are many points in the article that have been covered before in this Substack, but worth commenting some of the points made and how they relate to what we’ve discussed before.

“Nvidia is absolutely key to ensuring that AI is ultimately successful in healthcare,” Absci C…